Seven Bridges
Seven Bridges, founded in 2009, is the biomedical data analysis company accelerating breakthroughs in genomics research for cancer, drug development and precision medicine. The cloud-based Seven Bridges Platform empowers rapid, collaborative analysis of millions of genomes in concert with other forms of biomedical data. Thousands of researchers in government, biotech, pharmaceutical and academic labs use Seven Bridges, including three of the largest genomics projects in the world: U.S. National Cancer Institutes Cancer Genomics Cloud pilot, the Million Veteran Program, and Genomics Englands 100,000 Genomes Project. As the NIHs only commercial Trusted Partner, Seven Bridges authenticates and authorizes access to one of the worlds largest cancer genomics dataset. Named one of the worlds smartest companies by MIT Technology Review, Seven Bridges has offices in Cambridge, Mass.; Belgrade; London; Istanbul; and San Francisco.